SCHEMBL24529786

SCHEMBL24529786

FC(F)(F)c1ccc(SNC2CCNCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.51
MAPK1 P28482 1/20 0.44
HRH3 Q9Y5N1 3/20 0.43
HRH1 P35367 2/20 0.43
HRH4 Q9H3N8 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
HTR1A P08908 1/20 0.39
HTR3A P46098 1/20 0.39
KCNH2 Q12809 1/20 0.39
HTR6 P50406 2/20 0.38
PTGIR P43119 1/20 0.37
HAO1 Q9UJM8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24762157 0.78 FPR2 (0.36) HRH3CRBNSLC6A2SLC6A4HAO1
SCHEMBL1704613 0.75 HTR6 (0.57) HTR2CMAPK1SLC6A2SLC6A4KCNH2
SCHEMBL24529835 0.75 HTR2C (0.56) HTR2CMAPK1HRH3HRH1HRH4
Hydrochloric Acid SCHEMBL23303031 0.73 HTR6 (0.58) HTR2CMAPK1SLC6A2SLC6A4KCNH2
SCHEMBL20291420 0.73 EPHX2 (0.58)
SCHEMBL6901785 0.72 MAPT (0.43) CRBNKCNH2PTGIR
SCHEMBL26448460 0.71 HTR2C (0.51) HTR2CHRH3HRH1HRH4CYP3A4
SCHEMBL24393407 0.71 BCHE (0.57) HTR2CMAPK1HRH3SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL70804 0.71 HTR2C (0.51) HTR2CCYP2C19DDB1CRBNSLC6A2
SCHEMBL6785503 0.70 HDAC4 (0.62) HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022130352-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA CADILA HEALTHCARE LIMITED (IN) 2022-06-23 WO disclosed